B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Triaziquone

62 PubMed studies analyzed · Evidence Score: 39.5

Research Domains

Triaziquone has been studied across 11 research domains including 🔬 Oncology, ✨ Skin & Hair, 🧬 Hormones, ⚡ Energy & Fatigue, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 58% of studies addressing this area.

Loading evidence profile...

This evidence profile for Triaziquone is generated deterministically from 62 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.